Shares of the AdvisorShares Pure US Cannabis ETF (MSOS) have climbed to their highest levels of 2026, with investors positioning ahead of a June 29 DEA administrative hearing that could reshape how federal law treats marijuana. As of May 31, MSOS posted a 103.7% one-year net asset value return, well ahead of the North American Marijuana Index's 36.9% gain and the S&P 500's 29.8%. The fund managed $1.13 billion in assets as of June 5, and Trulieve Cannabis' fresh NYSE listing under the ticker TRLV has become the clearest signal yet that the industry's compliance and capital-markets picture is changing.
Here's the mechanism worth understanding: Trulieve split its medical cannabis operations from its adult-use business specifically to clear the bar for a senior exchange listing. That's not a cosmetic corporate move. Multi-state operators have spent years boxed out of major exchanges and traditional banking relationships because federal illegality made compliance officers at big institutions nervous. Splitting license structures, cleaning up entity ownership, and tightening seed-to-sale tracking across state METRC systems are the unglamorous groundwork that makes a listing like this possible. For operators watching from below, the operational lesson is the same one dispensary owners already live with on a smaller scale - inventory controls, audit-ready compliance logs, and clean books aren't back-office chores, they're what unlocks capital. That's true whether you're running a single storefront on cannabis dispensary management software california or managing a multi-state retail footprint chasing an uplisting. cannabis dispensary management software california
What the Rescheduling Fight Actually Changes
The June 29 hearing will examine whether cannabis, not just state-licensed medical products, should move to Schedule III. That distinction matters more than headlines suggest. In April, Acting Attorney General Todd Blanche moved licensed medical marijuana products into Schedule III, which lifted the 280E tax penalty for those operators - suddenly they could deduct payroll, rent, and interest like any other business instead of being taxed on gross profit. A broader move covering adult-use cannabis would extend that relief across most MSO revenue, not just the medical slice. Trump's formal nomination of Blanche as permanent attorney general has added to the bullish read, since it suggests continuity rather than a policy reversal mid-process.
Uplisting Momentum Builds Beyond Trulieve
Cresco Labs' $50 million revolving credit facility from Needham Bank, arranged the same week as Trulieve's listing, shows how rescheduling optimism is already loosening lending. CEO Charlie Bachtell described it as non-dilutive financing meant to fund acquisitions while positioning the company for U.S. capital markets access. That's the pattern to watch: improved balance sheets, better banking terms, and a queue of operators - Curaleaf, Green Thumb, Verano among them - eyeing the same senior-exchange path Trulieve just walked. Roth Capital called the rescheduling order "extremely favorable" for taxation, capital access, and overall investability, though it's worth remembering nothing is finalized until the hearing concludes, expected no later than July 15.
Reading the Upside Numbers With Some Caution
Price targets circulating among analysts show wide dispersion. Verano carries the steepest implied upside at 195%, followed by Jushi Holdings near 183% and Cresco Labs close to 99%. Green Thumb Industries, at 70% upside, outpaces both Trulieve and Curaleaf despite those two holding larger weights in MSOS. That gap between weighting and upside is a useful reminder for anyone watching the sector: size in a portfolio doesn't equal room to grow, and retail sentiment - extremely bullish chatter on platforms like Stocktwits included - tends to chase the biggest names rather than the best-positioned ones. For dispensary operators and wholesalers on the ground, the real signal isn't the stock price. It's whether easier banking, lower tax burden, and cheaper capital actually reach store-level operations, from POS terminals to compliant packaging costs to wholesale menu pricing.
